Sanofi Inks Two New Genomics Partnerships in Boston

January 11, 2012

January 11, 2012 | It's been a busy month for French pharma company Sanofi, as they ink deals with two Boston-based genomics firms, cancer diagnostic company Foundation Medicine and start-up Warp Drive Bio. Sanofi will invest $125 million in Warp Drive Bio, newly launched by venture capital firm Third Rock Ventures. The company, co-founded by Harvard chemistr Gregory Verdine and Harvard Medical School genomics pioneer George Church, will develop natural-product drugs using a proprietary genomics technology. Mass High Tech